· rebuilt nightly from public records
Signal Sheet
Headquartered in El Segundo, California, Qualigen Therapeutics is a publicly listed finance services company. It raised $4.5M in Jul 2025 and its filings name 7 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Campbell Becher | SEC filing, Jul 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Kevin Richardson II | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Braeden Lichti | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Robert B. Lim | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Cody Price | SEC filing, Jul 2025 | Technology and tooling decisions |
| Chief Technology Officer | Robert Lim | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Graydon Bensler | SEC filing, Nov 2024 | Technology and tooling decisions |
Signed a material agreement
Corporate eventOfficer or director change
New leadershipFiled to go public
CapitalThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 23, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Oct 23, 2026 | Completed an acquisition or sale | Corporate event | SEC filing |
| Oct 23, 2026 | Officer or director change | New leadership | SEC filing |
| Oct 14, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Aug 21, 2026 | Officer or director change | New leadership | SEC filing |
| Jul 29, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Jul 27, 2026 | Filed to go public | Capital | SEC filing |
| Jul 28, 2025 | Raised $4.5M in equity from 14 investors | Capital | SEC filing |
Lakewave finds the right people at Qualigen Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Qualigen Therapeutics with a free trial →| Headquarters | El Segundo, California, per the filing address |
| Industry group | Finance Services |
| Ownership | Listed company |
| Raise history | $5.1M (Nov 2024) · $4.5M (Jul 2025) |
| Lakewave Rising | 52 · 3 kinds of evidence · rank in California after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Qualigen Therapeutics reported a $4.5M equity raise to the SEC on Jul 28, 2025 with 14 investors.
The company's SEC filing, Jul 2025 names Campbell Becher (Executive Officer) among its officers.
El Segundo, California, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.